Get started
Dynavax Technologies CorporationDynavax Technologies CorporationDynavax Technologies Corporation

Dynavax Technologies Corporation

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

DVAX trade ideas

DVAX- Is Approaching A Critical Level: 50%/120% potential profitDVAX - Is Approaching A Critical Level: DVAX- Is Approaching A Critical Level: 50%/120% potential profit Here’s A Way to Play It. see chart info: DVAX Dynavax Technologies Corporation Healthcare | Biotechnology | USA NEWS for Dynavax Technologies Corporation : as of August 13, 2020 www.fool.com finance.yahoo.com DISCLAIMER: Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks and options may fluctuate, and, as a result, may lose more than their original investment. All trading strategies , CHART are used at your own risk. ...
NASDAQ:DVAXLong
by Voxeurh514
Almost done taking a Deep Breath and will try to Breakout AgainOn July 21 @ $11.31/share, I mentioned that DVAX is going to take a Deep Breath before trying to Breakout of the 16 Years Descending Triangle. By the time it closed on July 21, it created a Candlestick pattern of Evening Star (Bearish downtrend). Now it is about $8.61/share that is about 30% decline since then. Not too bad for people who shorted the stock. The Stochastic is approaching oversold, It is on Fib 0.382, On Trendline Support. Look for chart reversal pattern and confirmation before adding more. Best of luck and watch out for the overall market that might drag the stock down :) Evening Star created a very strong bearish trend, as a result. People ignored recent good news. This includes the following 1) Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate 2) Committee to vote on addition of the following medications to THMP formulary (Vote Required) HEPLISAV B Vote on July 31 hhs.texas.gov ------ List of Covid-19 Partnership Sinovac Biotech Clover clinicaltrials.gov Medicago clinicaltrials.gov Medigen clinicaltrials.gov Hep B Times Pharmacy, have partnered with Hep Free Hawaii to provide HEPLISAV-B Engerix-B vs HEPLISAV-B www.cdc.gov Universal influenza (flu) vaccine. DVAX announced that it has entered into a collaboration agreement with Icahn School of Medicine at Mount Sinai (Mount Sinai) to develop a universal influenza (flu) vaccine. HIV NIAID - clinicaltrials.gov NIAID - HBV Vaccination in Persons Living With HIV clinicaltrials.gov I believe there are several more studies or partners. Please post it here if I missed any. Happy Trading.
NASDAQ:DVAX
by joelam33
Collaboration to Develop a Universal Influenza Vaccine CandidateDynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant -Currently no approved universal influenza vaccine -CDC estimates 35.5 million people were infected with influenza in U.S. during 2018-2019 season -Mount Sinai’s current work in this area is funded under a contract award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), as part of the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program established by NIAID. -The development program will support an Investigational New Drug (IND) application for Phase I clinical trials. finance.yahoo.com
NASDAQ:DVAX
by AlenCiken